Rosellini Scientific, LLC Announces Recent Hire of Dr. Austin Duke as Vice President of Emerging Technologies
Rosellini Scientific, LLC is pleased to announce the recent hire of Dr. Austin Duke to join their team as Vice President of Emerging Technologies.
Dallas, TX, October 26, 2012 --(PR.com)-- Rosellini Scientific, LLC is pleased to announce the recent hire of Dr. Austin Duke to join their team as Vice President of Emerging Technologies. Most recently, Dr. Duke received his Master of Science and Doctoral degrees in Biomedical Engineering from Vanderbilt University; his research focused on the pre-clinical development of novel optical and electrical techniques for interacting with excitable biological tissues. Prior to Vanderbilt, he received a Bachelor’s Degree in Biomedical Engineering from North Carolina State University where he graduated Magna Cum Laude with a concentration in biomedical instrumentation. At Rosellini Scientific, Dr. Duke will be responsible for leading the pre-clinical research and development of novel medical devices. "Austin's research focus will be on combining optical and electrical methods of neural activation for the purpose of achieving a safe and reliable method of spatially specific nerve stimulation,” said Chief Medical Officer, Barry Kraynack, MD.
"Rosellini Scientific is focused on cutting edge technologies in neurotechnology. We distribute a number of products that utilize electrical and optical energies from existing medical device manufacturers. We expect to make significant headway researching hybrid stimulation technologies utilizing optogenetics/hybrid stimulation,” said President Emily Rosellini, MD.
About Rosellini Scientific, LLC:
Rosellini Scientific invests both expertise and capital in the development of medical technology that utilizes electricity to alter the nervous system. It collaborates with leading researchers and partners with pioneering universities and companies. As a global leader in the business of technology, it is creating an active market for translational medicine that connects buyers, sellers and inventors.
For more information, please contact julia@roselliniscientific.com or www.roselliniscientific.com.
"Rosellini Scientific is focused on cutting edge technologies in neurotechnology. We distribute a number of products that utilize electrical and optical energies from existing medical device manufacturers. We expect to make significant headway researching hybrid stimulation technologies utilizing optogenetics/hybrid stimulation,” said President Emily Rosellini, MD.
About Rosellini Scientific, LLC:
Rosellini Scientific invests both expertise and capital in the development of medical technology that utilizes electricity to alter the nervous system. It collaborates with leading researchers and partners with pioneering universities and companies. As a global leader in the business of technology, it is creating an active market for translational medicine that connects buyers, sellers and inventors.
For more information, please contact julia@roselliniscientific.com or www.roselliniscientific.com.
Contact
Rosellini Scientific, LLC
Emily Rosellini, MD
214-824-1200
www.roselliniscientific.com
2900 N. Fitzhugh Avenue
Suite 100
Dallas, TX 75204
Contact
Emily Rosellini, MD
214-824-1200
www.roselliniscientific.com
2900 N. Fitzhugh Avenue
Suite 100
Dallas, TX 75204
Categories